相关实验视频

Updated: Jan 16, 2026

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

免疫平台用于改善肺癌中新抗原预测

Stephanie J Hachey¹, Alexander G Forsythe², Hari B Keshava³

¹Molecular Biology and Biochemistry, University of California, Irvine, CA 92697, USA.

|September 27, 2025

概括

ImmuniT通过识别错过的目标来增强肺癌免疫疗法的新抗原发现. 这个平台改善了T细胞的激活,为那些对当前治疗没有反应的患者提供了新的希望.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物信息学是一种生物信息学.

背景情况:

肺癌是死亡的主要原因之一,由于瘤识别有限,免疫疗法反应不佳.
目前的新抗原发现方法错过了低或异质表达的目标.
免疫是一种新的平台,旨在增强新抗原的发现和验证.

研究的目的:

开发和验证ImmuniT,这是一个改进新抗原发现的平台.
为了识别传统方法错过的更广泛的新抗原谱.
为了增强T细胞激活,使肺癌免疫疗法更有效.

主要方法:

利用一个三相平台,涉及ex vivo瘤处理和自身T细胞共同培养.
综合突变,转录和HLA数据使用nextneopi管道进行新抗原预测.
通过MHC-epitope四聚体染色验证了预测的新抗原.

主要成果:

在五个患者样本中,ImmuniT发现了更广泛的新抗原.
与标准方法相比,在体外表现出更强的T细胞激活.
证实两种以前错过的新抗原在一个患者中引起了瘤特异性T细胞反应.

结论:

免疫T显示了扩大可操作瘤抗原的潜力.
该平台可以改善非响应患者的个性化免疫疗法策略.
增强的新抗原发现可能会克服当前肺癌治疗的局限性.

关键词:

免疫疗法免疫疗法肺癌是肺癌,肺癌是肺癌.新抗原是一种新抗原.个性化治疗是个性化的治疗.

更多相关视频

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.